Bilaketaren emaitzak - Gisèle Bonne

Findu emaitzak
  1. 1
    Emery–Dreifuss muscular dystrophy, laminopathies, and other nuclear envelopathies

    Emery–Dreifuss muscular dystrophy, laminopathies, and other nuclear envelopathies nork Gisèle Bonne, Susana Quijano-Roy

    Argitaratua 2013
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  2. 2
    “Laminopathies”: A wide spectrum of human diseases

    “Laminopathies”: A wide spectrum of human diseases nork Howard J. Worman, Gisèle Bonne

    Argitaratua 2007
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  3. 3
    Emery-Dreifuss muscular dystrophy

    Emery-Dreifuss muscular dystrophy nork A. Leclerc, Gisèle Bonne, Ketty Schwartz

    Argitaratua 2002
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  4. 4
    The 2018 version of the gene table of monogenic neuromuscular disorders (nuclear genome)

    The 2018 version of the gene table of monogenic neuromuscular disorders (nuclear genome) nork Gisèle Bonne, François Rivier, Dalil Hamroun

    Argitaratua 2017
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Targeted therapies for congenital myasthenic syndromes: systematic review and steps towards a treatabolome

    Targeted therapies for congenital myasthenic syndromes: systematic review and steps towards a treatabolome nork Rachel Thompson, Gisèle Bonne, Paolo Missier, Hanns Lochmüller

    Argitaratua 2019
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  6. 6
    The 2020 version of the gene table of neuromuscular disorders (nuclear genome)

    The 2020 version of the gene table of neuromuscular disorders (nuclear genome) nork Louise Benarroch, Gisèle Bonne, François Rivier, Dalil Hamroun

    Argitaratua 2019
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  7. 7
    The 2021 version of the gene table of neuromuscular disorders (nuclear genome)

    The 2021 version of the gene table of neuromuscular disorders (nuclear genome) nork Louise Benarroch, Gisèle Bonne, François Rivier, Dalil Hamroun

    Argitaratua 2020
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  8. 8
    The 2022 version of the gene table of neuromuscular disorders (nuclear genome)

    The 2022 version of the gene table of neuromuscular disorders (nuclear genome) nork Enzo Cohen, Gisèle Bonne, François Rivier, Dalil Hamroun

    Argitaratua 2021
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  9. 9
    The 2023 version of the gene table of neuromuscular disorders (nuclear genome)

    The 2023 version of the gene table of neuromuscular disorders (nuclear genome) nork Louise Benarroch, Gisèle Bonne, François Rivier, Dalil Hamroun

    Argitaratua 2022
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  10. 10
    The 2024 version of the gene table of neuromuscular disorders (nuclear genome)

    The 2024 version of the gene table of neuromuscular disorders (nuclear genome) nork Louise Benarroch, Gisèle Bonne, François Rivier, Dalil Hamroun

    Argitaratua 2023
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  11. 11
    Expression of human cytochrome <i>c</i>, oxidase subunits during fetal development

    Expression of human cytochrome <i>c</i>, oxidase subunits during fetal development nork Gisèle Bonne, Peter Seibel, Stefanie Possekel, C. Marsac, Bernhard Kadenbach

    Argitaratua 1993
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  12. 12
    Mitogen-Activated Protein Kinase Inhibitors Improve Heart Function and Prevent Fibrosis in Cardiomyopathy Caused by Mutation in Lamin A/C Gene

    Mitogen-Activated Protein Kinase Inhibitors Improve Heart Function and Prevent Fibrosis in Cardiomyopathy Caused by Mutation in Lamin A/C Gene nork Wei Wu, Antoine Muchir, Jian Shan, Gisèle Bonne, Howard J. Worman

    Argitaratua 2010
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  13. 13
    Pharmacological inhibition of c-Jun N-terminal kinase signaling prevents cardiomyopathy caused by mutation in LMNA gene

    Pharmacological inhibition of c-Jun N-terminal kinase signaling prevents cardiomyopathy caused by mutation in LMNA gene nork Wei Wu, Jian Shan, Gisèle Bonne, Howard J. Worman, Antoine Muchir

    Argitaratua 2010
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  14. 14
    Activation of MAPK in hearts of EMD null mice: similarities between mouse models of X-linked and autosomal dominant Emery–Dreifuss muscular dystrophy

    Activation of MAPK in hearts of EMD null mice: similarities between mouse models of X-linked and autosomal dominant Emery–Dreifuss muscular dystrophy nork Antoine Muchir, Paul Pavlidis, Gisèle Bonne, Yukiko Hayashi, Howard J. Worman

    Argitaratua 2007
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  15. 15
    Inhibition of extracellular signal-regulated kinase signaling to prevent cardiomyopathy caused by mutation in the gene encoding A-type lamins

    Inhibition of extracellular signal-regulated kinase signaling to prevent cardiomyopathy caused by mutation in the gene encoding A-type lamins nork Antoine Muchir, Jing Shan, Gisèle Bonne, Stephan E. Lehnart, Howard J. Worman

    Argitaratua 2008
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  16. 16
    ColVI myopathies: where do we stand, where do we go?

    ColVI myopathies: where do we stand, where do we go? nork Valérie Allamand, Laura Briñas, Pascale Richard, Tanya Stojkovic, Susana Quijano‐Roy, Gisèle Bonne

    Argitaratua 2011
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  17. 17
    Autophagic degradation of nuclear components in mammalian cells

    Autophagic degradation of nuclear components in mammalian cells nork Young-Eun Park, Yukiko Hayashi, Gisèle Bonne, Takuro Arimura, S. Noguchi, Ikuya Nonaka, Ichizo Nishino

    Argitaratua 2009
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  18. 18
    Primary Prevention of Sudden Death in Patients with Lamin A/C Gene Mutations

    Primary Prevention of Sudden Death in Patients with Lamin A/C Gene Mutations nork Christophe Meune, Jop H. van Berlo, Frédéric Anselme, Gisèle Bonne, Yigal M. Pinto, Denis Duboc

    Argitaratua 2006
    Testu osoa Testu osoa
    Carta
    Gogokoenen artean sartu
    Gorde:
  19. 19
    Targeting the histone demethylase LSD1 prevents cardiomyopathy in a mouse model of laminopathy

    Targeting the histone demethylase LSD1 prevents cardiomyopathy in a mouse model of laminopathy nork Anne-Claire Guénantin, Imen Jebeniani, Julia Leschik, Erwan Watrin, Gisèle Bonne, Nicolas Vignier, Michel Pucéat

    Argitaratua 2021
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  20. 20
    Treatment with selumetinib preserves cardiac function and improves survival in cardiomyopathy caused by mutation in the lamin A/C gene

    Treatment with selumetinib preserves cardiac function and improves survival in cardiomyopathy caused by mutation in the lamin A/C gene nork Antoine Muchir, Sarah A Reilly, W. Wu, Shinichi Iwata, Shunichi Homma, Gisèle Bonne, Howard J. Worman

    Argitaratua 2011
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: